NEW YORK, Feb 16 – Genaissance Pharmaceuticals has joined the Molecular Simulations’ Functional Genomics consortium, MSI said Friday.

Membership in this consortium gives Genaissance access to MSIs AtlasBase collection of functionally annoted gene sequences from 23 organisms and software that allows it to search this database, said Sue Rodney, manager of investor relations at Pharmacopeia, MSI’s parent company.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.